| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf .... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") | 2,809,679 | 28,078 | 30,491 | 49,081 | 50,036 | 2,967,365 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 49,295,189 | 45,352,786 | 47,105,801 | 48,772,348 | 48,602,366 | 239,128,490 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 0 | 0 | ||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | 0 | 0 | ||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | 0 | 0 | ||||
| 6 | Total. Add lines 1 through 5 | 52,104,868 | 45,380,864 | 47,136,292 | 48,821,429 | 48,652,402 | 242,095,855 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | 0 | 0 | 0 | 0 | 0 | 0 |
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | 0 | 0 | 0 | 0 | 0 | 0 |
| c | Add lines 7a and 7b.. | 0 | 0 | 0 | 0 | 0 | 0 |
| 8 | Public support. (Subtract line 7c from line 6.) | 242,095,855 | |||||
| Calendar year (or fiscal year beginning in) | (a) 2021 | (b) 2022 | (c) 2023 | (d) 2024 | (e) 2025 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6 | 52,104,868 | 45,380,864 | 47,136,292 | 48,821,429 | 48,652,402 | 242,095,855 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources | 850,968 | 1,348,211 | 1,540,393 | 2,049,175 | 2,003,479 | 7,792,226 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975 | 0 | 0 | ||||
| c | Add lines 10a and 10b | 850,968 | 1,348,211 | 1,540,393 | 2,049,175 | 2,003,479 | 7,792,226 |
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | 0 | 0 | ||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | 408,410 | 27,812 | 222,445 | 427,690 | 3,833 | 1,090,190 |
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 53,364,246 | 46,756,887 | 48,899,130 | 51,298,294 | 50,659,714 | 250,978,271 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6Total annual distributions. Add lines 1 through 5. | 6 | |
|
7
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
7 | |
| 8 Distributable amount for 2025 from Section C, line 6 | 8 | |
| 9 Line 7 amount divided by Line 8 amount | 9 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2025 |
(iii) Distributable Amount for 2025 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2025 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2025 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2025: | ||||
| a From 2020....... | ||||
| b From 2021....... | ||||
| c From 2022....... | ||||
| d From 2023....... | ||||
| e From 2024....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2025 distributable amount | ||||
|
i
Carryover from 2020 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2025 from Section D, line 6: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2025 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2025, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2025. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2026. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2021..... | ||||
| b Excess from 2022..... | ||||
| c Excess from 2023..... | ||||
| d Excess from 2024..... | ||||
| e Excess from 2025..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| SCHEDULE A, PART III, LINE 12 OTHER INCOME | DESCRIPTION - OTHER INCOME, COLUMN A - 408410.0, COLUMN B - 27812.0, COLUMN C - 222445.0, COLUMN D - 427690.0, COLUMN E - 3833.0, COLUMN F - 1090190.0; |
| Software ID: | 25022866 |
| Software Version: | 2025v4.2 |
| Return Reference | Explanation |
|---|---|
| FORM 990, PART III, LINE 4A CONTINUED PROGRAM SERVICE DESCRIPTION | THIS PROGRAM IS A SPECIALTY SERVICE OFFERED TO HOSPITAL CUSTOMERS BY PROVIDING ASSISTANCE FOR THERAPY PROCEDURES PRIMARILY INVOLVING THE REMOVAL OF VARIOUS BLOOD COMPONENTS FOR GRAVELY ILL PATIENTS. |
| FORM 990, PART III, LINE 4B CONTINUED PROGRAM SERVICE DESCRIPTION | THE COMPONENT MANUFACTURING DEPARTMENT IS RESPONSIBLE FOR MANUFACTURING BLOOD PRODUCTS FROM DONATED BLOOD THAT IS USED FOR PATIENT TRANSFUSION PURPOSES. COMPONENTS ARE MANUFACTURED BY SEPARATING THE DONATED BLOOD INTO SPECIFIC PRODUCTS. THESE PRODUCTS MAINLY INCLUDE RED BLOOD CELLS, PLATELETS AND PLASMA. SINCE ONE BLOOD DONATION CAN HELP UP TO THREE DIFFERENT PATIENTS IN NEED, THIS DEPARTMENT'S ROLE IS ENSURING THESE COMPONENT PRODUCTS ARE AVAILABLE TO CUSTOMERS AFTER THEY HAVE BEEN SUCCESSFULLY TESTED. THE PRODUCT MANAGEMENT DEPARTMENT IS RESPONSIBLE FOR THE STORAGE, DELIVERY AND TRANSPORTATION OF BLOOD AND BLOOD COMPONENTS TO CUSTOMERS. THIS AREA OF THE ORGANIZATION ALSO SERVES AS THE POINT OF CONTACT FOR LIFESERVE BLOOD CENTER'S HOSPITAL CUSTOMERS. |
| FORM 990, PART III, LINE 4D DESCRIPTION OF OTHER PROGRAM SERVICES | (EXPENSES $ 14,781,924 INCLUDING GRANTS OF $ 0)(REVENUE $ 0) QUALITY: THE QUALITY DEPARTMENT AT LIFESERVE BLOOD CENTER IS RESPONSIBLE FOR ENSURING THE SAFETY AND QUALITY OF THE BLOOD AND BLOOD PRODUCTS COLLECTED, TESTED AND DISTRIBUTED TO CUSTOMERS. THE FUNCTION OF THIS AREA OF THE COMPANY IS TO ENSURE THAT ALL EMPLOYEES AND VENDORS ARE WORKING WITHIN GUIDELINES AND STANDARD OPERATING PROCEDURES SET BY REGULATORY AGENCIES SUCH AS THE FDA (FOOD AND DRUG ADMINISTRATION) AND AABB (ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES). ADDITIONALLY, THIS AREA IS RESPONSIBLE FOR HANDLING ALL TRAINING PROGRAMS FOR LIFESERVE BLOOD CENTER STAFF TO ENSURE PROPER COMPETENCY TO PERFORM VITAL JOB FUNCTIONS. THE QUALITY DEPARTMENT ALSO LEADS THE ORGANIZATION'S PROCESS IMPROVEMENT EFFORTS, ENSURING EFFICIENT AND EFFECTIVE OPERATIONS. EXPENSE $901,812. INCLUDING GRANTS OF $ 0. REVENUE $ 0. FLEET, FACILITIES AND PURCHASING: THE FLEET, FACILITIES AND PURCHASING DEPARTMENT AT LIFESERVE BLOOD CENTER IS RESPONSIBLE FOR FURNISHING THE OPERATIONS DEPARTMENT WITH THE VEHICLES AND FACILITIES USED TO COLLECT BLOOD PRODUCTS AT BOTH MOBILE AND FIXED SITE OPERATIONS. THIS IS ACHIEVED THROUGH A COMBINATION OF LARGE BUSES, VANS, AND TRAILERS TO ACCOMMODATE THE DONATION PROCESS, AS WELL AS FIXED SITE LOCATIONS ACROSS THE REGION, WHERE DONORS CAN COME AND MAKE THEIR LIFE-SAVING BLOOD DONATION. THIS DEPARTMENT IS ALSO RESPONSIBLE FOR PURCHASING ALL SUPPLIES FOR THE ORGANIZATION. EXPENSES $3,868,186. INCLUDING GRANTS OF $ 0. REVENUE $ 0. PUBLIC RELATIONS AND MARKETING: THE PUBLIC RELATIONS AND MARKETING DEPARTMENT IS RESPONSIBLE FOR ALL MARKETING, PUBLIC RELATIONS AND COMMUNICATION EFFORTS NEEDED TO ENGAGE INDIVIDUALS TO BECOME BLOOD DONORS. THIS DEPARTMENT IS ALSO RESPONSIBLE FOR ENSURING A POSITIVE COMMUNITY IMAGE THROUGH VISIBILITY EVENTS AND BRAND AWARENESS EFFORTS. ADDITIONALLY, THIS AREA OF THE ORGANIZATION ALSO HANDLES AND/OR PERFORMS ALL MEDIA OUTREACH. AS A PART OF THE PUBLIC RELATIONS AND MARKETING DEPARTMENT, LIFESERVE BLOOD CENTER MANAGES A VOLUNTEER OUTREACH PROGRAM SPECIFICALLY GEARED TOWARD ENGAGING VOLUNTEERS TO PERFORM A WIDE VARIETY OF OPERATIONAL TASKS AND FUNCTIONS FOR THE ORGANIZATION. THESE UNPAID INDIVIDUALS HELP TRANSPORT BLOOD TO AND FROM HOSPITALS, PERFORM FILING AND/OR CLERICAL DUTIES AS WELL AS HELP ENSURE SUPPLIES ARE PACKED AND RECEIVED APPROPRIATELY. THIS OUTREACH PROGRAM IS EXTREMELY VITAL TO THE OPERATION OF THE ORGANIZATION BY PROVIDING ADDITIONAL RESOURCES WITHOUT INCURRING EXTRA EXPENSE. EXPENSE $1,556,563. INCLUDING GRANTS OF $ 0. REVENUE $ 0. |
| FORM 990, PART VI, LINE 11B REVIEW OF FORM 990 BY GOVERNING BODY | THE 990 IS PREPARED AND REVIEWED BY AN INDEPENDENT ACCOUNTING FIRM AND THEN IT IS REVIEWED BY THE CFO. BOTH THE FINANCE COMMITTEE OF THE BOARD AND THE BOARD WILL REVIEW AND DISCUSS THE COMPLETED FORM 990 BEFORE IT IS FILED. ANY QUESTIONS OR COMMENTS RELATED TO ITS PREPARATION WILL BE DOCUMENTED BY ACCOUNTING STAFF AND FORWARDED TO THE INDEPENDENT ACCOUNTING FIRM PREPARING THE RETURN FOR REVISION AND RECONCILIATION. AFTER THE REVIEW HAS BEEN COMPLETED AND ANY CHANGES HAVE BEEN MADE, THE FULL BOARD RECEIVES A COPY BEFORE IT IS FILED. |
| FORM 990, PART VI, LINE 12C CONFLICT OF INTEREST POLICY | BOARD MEMBERS AND SENIOR LEADERSHIP ANNUALLY REVIEW AND SIGN THE CONFLICT OF INTEREST POLICY. ALL SIGNIFICANT TRANSACTIONS ARE REVIEWED BY MANAGEMENT, OR THE BOARD IF APPROPRIATE, TO ENSURE COMPLIANCE. IF A CONFLICT ARISES, AFTER EXERCISING DUE DILIGENCE, THE BOARD WOULD DETERMINE WHETHER LIFESERVE BLOOD CENTER CAN OBTAIN WITH REASONABLE EFFORTS AN ARRANGEMENT WITH A PERSON OR ENTITY THAT DOES NOT GIVE RISE TO A CONFLICT. IF A MORE ADVANTAGEOUS ARRANGEMENT IS NOT POSSIBLE, A DECISION IS MADE BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS. |
| FORM 990, PART VI, LINE 15A PROCESS TO ESTABLISH COMPENSATION OF TOP MANAGEMENT OFFICIAL | THE BOARD OF DIRECTORS HAS A HUMAN RESOURCE COMMITTEE. THE RESPONSIBILITIES OF THE HR COMMITTEE ARE DEFINED IN A COMMITTEE CHARTER. THESE RESPONSIBILITES INCLUDE DETERMINATION OF CEO COMPENSATION AND COMPENSATION PHILOSOPHY. A CONSULTING FIRM WAS HIRED TO ESTABLISH RANGES BASED ON MARKET COMPENSATION OF COMPARABLE ORGANIZATIONS. THE CONSULTING FIRM PROVIDED THIS INFORMATION TO THE HR COMMITTEE. THE COMPARABILITY DATA USED INCLUDED OTHER BLOOD CENTERS, OTHER NON-PROFITS AND OTHER REGIONAL ORGANIZATIONS. THE DETERMINATION OF EXECUTIVE SALARY RANGES WAS DOCUMENTED IN A SUMMARY REPORT CREATED BY THE CONSULTANT, AS WELL AS IN HR COMMITTEE AND BOARD MINUTES. THE CEO SALARY RANGE IS EVALUATED EVERY 3-4 YEARS BY HIRING A CONSULTING FIRM TO ASSESS THE MARKET RANGE. THE LAST MARKET EVALUATION WAS PERFORMED IN THE SECOND AND THIRD QUARTERS OF 2025 FOR IMPLEMENTATION IN THE SECOND QUARTER OF 2026. THE PLACEMENT OF THE CEO WITHIN THE RANGE WAS DONE BASED ON RECOMMENDATIONS FROM THE COMPENSATION CONSULTING FIRM. THE CEO'S PERFORMANCE IS REVIEWED BY THE HR COMMITTEE. THE HR RECOMMENDATION FOR SALARY INCREASE IS TAKEN TO THE FULL BOARD FOR APPROVAL. |
| FORM 990, PART VI, LINE 15B PROCESS TO ESTABLISH COMPENSATION OF OTHER EMPLOYEES | EVERY 3 YEARS A COMPENSATION CONSULTANT IS HIRED TO CONDUCT A MARKET EVALUATION FOR ALL POSITIONS IN THE ORGANIZATION. OTHER BLOOD CENTERS, NON-PROFITS AND REGIONAL ORGANIZATIONS WERE USED TO ESTABLISH THE SALARY RANGES. THE LIFESERVE COMPENSATION PHILOSOPHY IS MARKET BASED. OUR GOAL IS TO PROVIDE FAIR COMPENSATION BASED ON THE MARKET SALARY FOR THE POSITION. THE MARKET EVALUATION WAS USED TO CREATE A SALARY RANGE FOR ALL EMPLOYEES IN THE ORGANIZATION. EMPLOYEES ARE PLACED IN THE RANGE BASED ON EXPERIENCE AND PERFORMANCE. AN EMPLOYEES' ABILITY TO ADVANCE IN THE SALARY RANGE IS BASED ON PERFORMANCE. MERIT INCREASES ARE DETERMINED BY PLACEMENT IN THE RANGE AND BUDGET. THE COMPLETE MARKET ANALYSIS WAS MOST RECENTLY PERFORMED IN THE SECOND AND THIRD QUARTERS OF 2025 AND WAS IMPLEMENTED IN THE FOURTH QUARTER OF 2025. |
| FORM 990, PART VI, LINE 19 REQUIRED DOCUMENTS AVAILABLE TO THE PUBLIC | THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. |
| FORM 990, PART VIII, LINE 2F OTHER PROGRAM SERVICE REVENUE | THERAPEUTIC AND CELLULAR PROCEDURES - TOTAL REVENUE: 555801, RELATED OR EXEMPT FUNCTION REVENUE: 555801, UNRELATED BUSINESS REVENUE: , REVENUE EXCLUDED FROM TAX UNDER SECTIONS 512, 513, OR 514: ; |
| Software ID: | 25022866 |
| Software Version: | 2025v4.2 |